Zein Protein Nanoparticles Deliver Anticancer Peptides for Head and Neck Cancer Treatment

Zein protein nanoparticles loaded with anticancer peptides showed enhanced anti-tumor activity against head and neck squamous cell carcinoma through improved stability, cellular uptake, and sustained release.

Jenča, Andrej et al.·Nanomaterials (Basel·2026·
RPEP-153762026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Zein NPs loaded with anticancer peptides: enhanced stability, cellular uptake, sustained release, and improved anti-tumor activity against HNSCC compared to free peptide.

Key Numbers

How They Did This

Zein nanoparticle fabrication and peptide loading, characterization (size, release kinetics), cellular uptake studies, and anti-tumor activity assessment in HNSCC cells.

Why This Research Matters

HNSCC needs better drug delivery. Zein NPs provide a food-grade, FDA-approved delivery platform for anticancer peptides.

The Bigger Picture

Food-grade protein nanoparticles represent a safe, scalable, and affordable delivery platform for peptide-based cancer therapies.

What This Study Doesn't Tell Us

In vitro only. HNSCC cell lines may not fully represent clinical tumors. In vivo efficacy not tested.

Questions This Raises

  • ?Would zein NPs improve peptide delivery in animal HNSCC models?
  • ?Can zein NPs be functionalized with targeting peptides for tumor selectivity?
  • ?How does zein NP cost compare to PLGA nanoparticles?

Trust & Context

Key Stat:
Food-grade cancer delivery Corn protein (zein) nanoparticles — FDA-approved and food-grade — effectively deliver anticancer peptides to head and neck cancer cells
Evidence Grade:
In vitro proof-of-concept. Food-grade delivery platform with characterization.
Study Age:
Published in 2025.
Original Title:
Treatment of Maxillofacial Cancers by Zein Nanoparticles Loaded with Anticancer Peptide Pistacia Zardin1: Enhanced Cytotoxicity and Apoptosis Induction in Head and Neck Squamous Cell Carcinoma (HNSCC).
Published In:
Nanomaterials (Basel, Switzerland), 16(4) (2026)
Database ID:
RPEP-15376

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What are zein nanoparticles?

Tiny particles made from zein (a corn protein) that can carry drugs. They are FDA-approved, biodegradable, and naturally food-safe — ideal for drug delivery.

How do they help fight cancer?

They protect anticancer peptides from degradation, help them enter cancer cells more efficiently, and release the drug slowly for sustained effect — improving anti-tumor activity.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-15376·https://rethinkpeptides.com/research/RPEP-15376

APA

Jenča, Andrej; Saberian, Elham; Jenčová, Janka; Petrášová, Adriána; Jenča, Andrej; Mills, David; Zare-Zardini, Hadi; Kubíková, Eliška; Dianišková, Simona; Pyndus, Tetyana. (2026). Treatment of Maxillofacial Cancers by Zein Nanoparticles Loaded with Anticancer Peptide Pistacia Zardin1: Enhanced Cytotoxicity and Apoptosis Induction in Head and Neck Squamous Cell Carcinoma (HNSCC).. Nanomaterials (Basel, Switzerland), 16(4). https://doi.org/10.3390/nano16040254

MLA

Jenča, Andrej, et al. "Treatment of Maxillofacial Cancers by Zein Nanoparticles Loaded with Anticancer Peptide Pistacia Zardin1: Enhanced Cytotoxicity and Apoptosis Induction in Head and Neck Squamous Cell Carcinoma (HNSCC).." Nanomaterials (Basel, 2026. https://doi.org/10.3390/nano16040254

RethinkPeptides

RethinkPeptides Research Database. "Treatment of Maxillofacial Cancers by Zein Nanoparticles Loa..." RPEP-15376. Retrieved from https://rethinkpeptides.com/research/jenca-2026-treatment-of-maxillofacial-cancers

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.